Skip to content

Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05436327
Enrollment
479
Registered
2022-06-29
Start date
2022-05-06
Completion date
2027-01-31
Last updated
2026-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Cancer, Communication

Brief summary

To improve patient-centered outcomes for older patients with cancer considering or receiving chemotherapy and their caregivers. To do this, the project team will (a) establish the effectiveness of GA on communication about age-related concerns, patient and caregiver satisfaction with communication about age-related concerns, quality of life, and patient-reported side effects of chemotherapy; (b) evaluate the success of the implementation strategies on the adoption, reach, and fidelity of implementing the GA in community oncology practices; and (c) identify the resources needed to implement GA and the GA-guided recommendations in community oncology practices for older patients considering or receiving chemotherapy.

Detailed description

Objectives: * Establish the effectiveness of GA on patient and caregiver satisfaction and communication about age-related concerns for older patients receiving chemotherapy in community oncology practices. * Evaluate the success of our implementation strategies on the reach, adoption, and fidelity of implementing the GA in community oncology practices. * Identify the resources needed to implement GA and the GA-guided recommendations in community oncology practices for older patients receiving chemotherapy.

Interventions

BEHAVIORALGeriatric Assessment

Clinical staff receive (a) training in GA and workflow management strategies (\<60 minutes) at baseline, (b) monthly facilitation and technical support calls (15-30 minutes) for 12 months, and (c) a group-based quarterly call for 12 months. For 12 months, clinical staff implement GA strategies during visits with older adult (65+) patients planning to receive new chemotherapy regimen and their care partners/caregivers.

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER
Patient-Centered Outcomes Research Institute
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Practice Staff Participants Inclusion Criteria: * Aged 18 years or older * A practicing clinician (e.g., oncologist, nurse practitioners, physician assistant, advanced practice nurse, registered nurse, medical assistant) or other practice staff (e.g., administrators and IT) * Fluent in English (reading and speaking) * Have access to computer, laptop, tablet, or smart phone

Exclusion criteria

* Have plans to leave the practice in six months (e.g., retiring or changing organizations) * Unable to provide consent Patient Participants Inclusion Criteria: * Aged 65 and older * Considering a new chemotherapy plan

Design outcomes

Primary

MeasureTime frameDescription
Reach of Geriatric Assessment (GA) implementation in routine medical practicemonthly over 12 months of implementation, and 6 months after implementation
Reach of Geriatric Assessment (GA) implementation in routine medical practice as measured by applying the reach formula (# people served divided by potential # of people) to the following four metrics:monthly over 12 months of implementation, and 6 months after implementationa) patients per month who received the Geriatric Assessment (GA), b) patients per month who received Geriatric Assessment (GA)-guided recommendations, c) total patients per month age 65+, d) total patients per month who were age 65+ and receiving new chemotherapy or deciding to start chemotherapy.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLisa Marie Lowenstein, PhD, MPH

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 17, 2026